You have 9 free searches left this month | to do more

apixaban

Apixaban is a drug used to treat Atrial Fibrillation, Venous Thromboembolism, Pulmonary Embolism, and other conditions. Apixaban is being actively studied in 45 studies and prior, has been studied in 77.

Top SponsorsTop SitesTop Investigators
Bristol-Myers SquibbLocal InstitutionJeffrey Kline
PfizerDuke University Medical CenterJessica Franklin
BayerHenry Ford HospitalScott C. Woller, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Expanded Access for Apixaban
Available
    • Apixaban
    • (no location specified)
    2021-12-22
    Dec 22, 2021
    U
    A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma - 2019
    Terminated
    Has Results
    • Anti-Xa Activity
    • apixaban
    • Vancouver, British Columbia, Canada
      Vancouver General Hospital
    2021-07-28
    Jul 28, 2021
    S
    Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
    Not yet recruiting
    • COVID-19
    • Apixaban
    • (no location specified)
    2021-10-21
    Oct 21, 2021
    A
    Apixaban for Extended Anticoagulation (APIDULCIS)
    Recruiting
    • Venous Thromboembolism
    • Anticoagulants
    • Apixaban
    • Firenze, Italy
      Daniela Poli
    2021-03-18
    Mar 18, 2021
    T
    Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy - 2021
    Completed
    • Pancreas Cancer
    • +2 more
    • Apixaban
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Clinical Research Unit
    2021-12-06
    Dec 6, 2021
    P
    Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices
    Not yet recruiting
    • Heart Failure
    • Apixaban
    • +2 more
    • Falls Church, Virginia
      Inova Fairfax Medical Campus
    2021-11-08
    Nov 8, 2021
    A
    Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
    Recruiting
    • Intrahepatic Non Cirrhotic Portal Hypertension
    • Apixaban
    • Placebo
    • Clichy, France
      Beaujon hospital
    2021-02-24
    Feb 24, 2021
    U
    Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients - 2020
    Completed
    • Pharmacokinetics
    • +2 more
    • Apixaban
    • Saskatoon, Saskatchewan, Canada
      Saskatchewan Health Authority
    2021-04-28
    Apr 28, 2021
    I
    Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
    Suspended
    • Deep Venous Thrombosis
    • +4 more
    • apixaban
    • Murray, Utah
      Intermountain Medical Center
    2021-08-24
    Aug 24, 2021
    N
    Bariatric Surgery and Pharmacokinetics of Apixaban
    Recruiting
    • Obesity, Morbid
    • Apixaban
    • Trondheim, Norway
      St. Olavs University Hospital
    2021-03-03
    Mar 3, 2021
    A
    A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
    Not yet recruiting
    • Venous Thromboembolism
    • +2 more
    • Abelacimab
    • Apixaban
    • (no location specified)
    2021-12-23
    Dec 23, 2021
    J
    Apixaban Pharmacokinetics in Bariatric Patients (APB) - 2020
    Completed
    Has Results
    • Bariatric Surgery
    • Obesity
    • Apixaban
    • Baltimore, Maryland
      The Johns Hopkins Center for Bariatric Surgery
    2020-12-01
    Dec 1, 2020
    O
    COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
    Recruiting
    • Atrial Fibrillation
    • Ottawa, Ontario, Canada
      The Ottawa Hospital - General Campus
    2021-10-29
    Oct 29, 2021
    O
    Comparison of Bleeding Risk Between Rivaroxaban and Apixaban - 2018
    Completed
    • Venous Thromboembolism
    • Edmonton, Alberta, Canada
    • +3 more
    2021-10-31
    Oct 31, 2021
    M
    Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation - 2020
    Terminated
    Has Results
    • Atrial Fibrillation
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    2021-02-23
    Feb 23, 2021
    U
    Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation - 2019
    Completed
    Has Results
    • Transient Ischemic Attack
    • +2 more
    • Torrance, California
    • +4 more
    2021-11-03
    Nov 3, 2021
    A
    Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
    Recruiting
    • Atrial Fibrillation
    • End-stage Kidney Disease
    • Münster, Germany
      Universitätsklinikum Münster
    2021-04-26
    Apr 26, 2021
    M
    Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT) - 2019
    Terminated
    Has Results
    • Heparin-induced Thrombocytopenia
    • Heparin-induced Thrombocytopenia and Thrombosis
    • Apixaban
    • Boston, Massachusetts
    • +2 more
    2020-11-29
    Nov 29, 2020
    S
    Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
    Active, not recruiting
    • Antiphospholipid Syndrome
    • Thrombosis
    • Columbus, Ohio
    • +1 more
    2021-08-24
    Aug 24, 2021
    P
    Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT - 2019
    Completed
    • Healthy
    • Secaucus, New Jersey
      Frontage Clinical Services Inc.
    2020-09-01
    Sep 1, 2020
    S
    Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation - 2019
    Completed
    Has Results
    • Coronary Artery Bypass Grafting
    • +4 more
    • Fargo, North Dakota
      Sanford Health
    2020-12-28
    Dec 28, 2020
    B
    Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis
    Recruiting
    • Deep Vein Thrombosis
    • Malignancy
    • Banī Suwayf, Beni-Suef, Egypt
      Faculty of Medicine,Beni-Suef University
    2020-07-03
    Jul 3, 2020
    N
    Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation
    Withdrawn
    • Atrial Fibrillation
    • (no location specified)
    2020-10-05
    Oct 5, 2020
    N
    Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism
    Recruiting
    • Venous Thromboembolism
    • Apixaban
    • Valhalla, New York
      New York Medical College
    2020-09-08
    Sep 8, 2020
    S
    Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.
    Recruiting
    • Critical Limb Ischemia
    • Apixaban
    • +2 more
    • São Paulo, Brazil
      IAMSPE - Sao Paulo Public Servants Hospital
    2021-04-17
    Apr 17, 2021